James Barton (@jimbo6607) 's Twitter Profile
James Barton

@jimbo6607

ID: 4547728332

calendar_today13-12-2015 14:17:46

8,8K Tweet

397 Followers

1,1K Following

Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/Prime Medicine has presented an impressive updated Preclinical data for its leading Ex-Vivo #PrimeEditing program – PM359 for the treatment of chronic granulomatous disease #CGD. #CRISPR #BioTech #GeneEditing $PRME David R. Liu #Genomics #ASGCT23 #ASGCT2023 🧵👇

1/<a href="/PrimeMedicine/">Prime Medicine</a> has presented an impressive updated Preclinical data for its leading Ex-Vivo #PrimeEditing program – PM359 for the treatment of chronic granulomatous disease #CGD. #CRISPR #BioTech #GeneEditing $PRME <a href="/davidrliu/">David R. Liu</a> #Genomics #ASGCT23 #ASGCT2023 🧵👇
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/CRISPR Therapeutics & Vertex Pharmaceuticals announced that both trials for $CRSP & $VRTX exa-cel (CTX-001) in patients with #BetaThalassemia #TDT or severe #SickleCell disease #SCD have met primary & key secondary endpoints at pre-specified interim analyses! #CRISPR #BioTech #Genomics #EHA2023

1/<a href="/CRISPRTX/">CRISPR Therapeutics</a> &amp; <a href="/VertexPharma/">Vertex Pharmaceuticals</a> announced that both trials for $CRSP &amp; $VRTX exa-cel (CTX-001) in patients with #BetaThalassemia #TDT or severe #SickleCell disease #SCD have met primary &amp; key secondary endpoints at pre-specified interim analyses! #CRISPR #BioTech #Genomics #EHA2023
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/SparingVision has recently presented promising preclinical data of its second clinical program - SPVN20 - #GeneTherapy aimed to treat late stage #RetinitisPigmentosa patients by restoring the function of dormant #Cone #Photoreceptors #cells. #BioTech #Genomics #ASGCT2023 $NTLA

1/<a href="/SparingVision/">SparingVision</a> has recently presented promising preclinical data of its second clinical program - SPVN20 - #GeneTherapy aimed to treat late stage #RetinitisPigmentosa patients by restoring the function of dormant #Cone #Photoreceptors #cells. #BioTech #Genomics #ASGCT2023 $NTLA
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/Beam Therapeutics has issued a corporate update - as part of its #JPM2024 presentation in which $BEAM reported: 1)recent business progress 2)highlighted its strategic priorities for 2024 3)presented the clinical progress the company achieved in 2023. #BioTech #CRISPR #GeneEditing #JPM24

1/<a href="/BeamTx/">Beam Therapeutics</a> has issued a corporate update - as part of its #JPM2024 presentation in which $BEAM reported: 1)recent business progress 2)highlighted its strategic priorities for 2024 3)presented the clinical progress the company achieved in 2023. #BioTech #CRISPR #GeneEditing #JPM24
James Barton (@jimbo6607) 's Twitter Profile Photo

Don't mind me while I try to get my Dinamita bag 🔥💰💥 Don’t worry, You can too! Just tap below to post, and include @doritos, #DinamitaDinero and #entry for the chance to win!​ ​ 21+/USOnly/NoPurchNec/Rules: bit.ly/3OtmhW7

James Barton (@jimbo6607) 's Twitter Profile Photo

Don't mind me while I try to get my Dinamita bag 🔥💰💥 Don’t worry, You can too! Just tap below to post, and include @doritos, #DinamitaDinero and #entry for the chance to win!​ ​ 21+/USOnly/NoPurchNec/Rules: bit.ly/3OtmhW7

Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

A great conversation on Bloomberg with @doudna_lab about her breakthrough invention that would change the world - CRISPR Gene editing, CRISPR Therapeutics first ever U.S. FDA approval of $CRSP CASGEVY, the Co-founding of Intellia Therapeutics, Verve Therapeutics’s huge potential & much more. $VERV $NTLA $XBI

Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/As promised & after reading $NTLA latest Q4 & full year 2023 financial report here is my impression regarding Intellia Therapeutics latest corporate status. As always I have focused only on the main issues that I found to be the most interesting & relevant. Here is my 🧵👇 $XBI #BioTech

1/As promised &amp; after reading $NTLA latest Q4 &amp; full year 2023 financial report here is my impression regarding <a href="/intelliatx/">Intellia Therapeutics</a> latest corporate status. As always I have focused only on the main issues that I found to be the most interesting &amp; relevant. Here is my 🧵👇 $XBI #BioTech
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/As promised and after reading $VERV latest Q4 & full year 2023 financial report here is my impression regarding Verve Therapeutics latest corporate status. As always - I have focused only on the main issues that I found to be the most interesting & relevant. Here’s my🧵👇 $XBI #BioTech

1/As promised and after reading $VERV latest Q4 &amp; full year 2023 financial report here is my impression regarding <a href="/VerveTx/">Verve Therapeutics</a> latest corporate status. As always - I have focused only on the main issues that I found to be the most interesting &amp; relevant. Here’s my🧵👇 $XBI #BioTech
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

WOW! CRISPR & Base Gene editing have made it into today’s front page of the The Wall Street Journal! Betsy McKay talked with Intellia’s CEO John Leonard & Verve’s CEO Sek Kathiresan MD about how genetic medicine changed patients lives - Intellia Therapeutics & Regeneron $NTLA-2001 & Verve Therapeutics $VERV-101. #HOPE! $XBI

WOW! CRISPR &amp; Base Gene editing have made it into today’s front page of the <a href="/WSJ/">The Wall Street Journal</a>! <a href="/betswrites/">Betsy McKay</a> talked with Intellia’s CEO John Leonard &amp; Verve’s CEO <a href="/skathire/">Sek Kathiresan MD</a> about how genetic medicine changed patients lives - <a href="/intelliatx/">Intellia Therapeutics</a> &amp; <a href="/Regeneron/">Regeneron</a> $NTLA-2001 &amp; <a href="/VerveTx/">Verve Therapeutics</a> $VERV-101. #HOPE! $XBI
Yair Einhorn (@yaireinhorn) 's Twitter Profile Photo

1/After the success of $NVO & $LLY GLP-1 drugs - such as Wegovy, obesity is now a modern day BioTech gold rush backed by an unprecedented capital inflow & new pipelines. According to Stifel there are currently 264 programs for obesity either approved or in development!🧵👇 $XBI

1/After the success of $NVO &amp; $LLY GLP-1 drugs - such as Wegovy, obesity is now a modern day BioTech gold rush backed by an unprecedented capital inflow &amp; new pipelines. According to <a href="/Stifel/">Stifel</a> there are currently 264 programs for obesity either approved or in development!🧵👇 $XBI
Marcus Lemonis (@marcuslemonis) 's Twitter Profile Photo

I’ll accept your bag of LAY'S and raise you a Camping World Rv to give away Retweet if you want to be selected the WINNER of an RV filled with LAY'S #LaysVsCampingWorld

James Barton (@jimbo6607) 's Twitter Profile Photo

Marcus Lemonis Camping World To me, it would mean wherever I go with it I would display my American patriotism and my love for America and to all military personnel, police, and other service members who put their lives on the line every day for us.